| 5-FU | 5-fluorouracil |
| DPD | Dihydropyrimidine dehydrogenase |
| SNPs | Single nucleotide polymorphisms |
| LD | Linkage disequilibrium |
| WES | Whole exome sequencing |
| PharmVar | Pharmacogene Variation Consortium |
| CPIC® | Clinical Pharmacogenetics Implementation Consortium |
| EMA | European Medicine Agency |
| EPAR | European Public Assessment Reports |
| AEMPS | Spanish Agency for Medicines and Health Products |
| Swissmedic | Swiss Agency for Therapeutic Products |
| FDA | Food and Drug Administration |
| DPWG | Dutch Pharmacogenetics Working Group |
| AIOM | Italian Association of Medical Oncology |
| SIF | Italian Society of Pharmacology |
| RNPGx | French National Network of Pharmacogenetics |
| SEFF/SEOM | Pharmacogenomics Society and the Spanish Society of Medical Oncology |
| FPGMX | Pharmacogenetic Unit of the Public Foundation of Genomic Medicine |
| HER2 | Human Epidermal Growth Factor Receptor 2 |